Page 164 - Access Program News Today

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

The FDA approved Delcath Systems Inc's (NASDAQ: DCTH) HEPZATO KIT (melphalan/Hepatic Delivery System). 

- Seelos expects to release top-line data in its registration directed study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation ...

Back to School Event Kicks Off New Partnership

In a recent press release from the Ohio Department of Health, or ODH, Dr. Bruce Vanderhoff, the department’s director, offered assurances that the COVID-19 vaccine will continue to be readily available to Ohioans, including the uninsured, as the vaccine supply moves to a more traditional healthcare

For the first time in almost 40 years, the FAFSA will be streamlined so more students can access it and receive financial aid.

Town secures funding for project

Viant Technology Inc. (NASDAQ:DSP) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Hello, everyone. And welcome to Viant’s Second Quarter 2023 Earnings Conference Call. My name is Catherine, and I will be your operator today. Before I hand the call over to Viant’s leadership team, I’d like to go over just a few housekeeping […]

In Sydney, Australia, Talent has announced a brand-new internal initiative aimed at helping youth employment. The 1 in 10 pledge states that for every 10 Talent employees, there will be 1 Talent team member globally that is RISE related (RISE team and RISE young people placed in Talent). The business is currently at 1 in 19 and aims to achieve 1 in 10 by 2026.  

Value and versatility of underutilized pork, beef and lamb cuts were a focus of the event.